Quick Answer
RenovoRx, Inc. reported Total Revenue of $1.12 million for fiscal year 2025.
RenovoRx, Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $1.12M | +2511.6% |
| 2024 | $43.0K | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $266.0K | — | -37.0% |
| June 30, 2025 | $422.0K | — | +114.2% |
| March 31, 2025 | $197.0K | — | — |
- RenovoRx, Inc. showed an increase of +2511.6% in Total Revenue compared to the prior fiscal year.
- Over the 2024–2025 period, RenovoRx, Inc.’s total revenue has grown by 2511.6% (from $43.0 thousand to $1.12 million).
- The most recent figure is from RenovoRx, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: